Overview
Claire Haegelen practices in Bron, France. Ms. Haegelen is rated as an Advanced expert by MediFind in the treatment of Parkinson's Disease. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Epilepsy, Deep Brain Stimulation, and Cordotomy.
Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 35 articles in the study of Parkinson's Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CordotomyMs. Haegelen isDistinguished. Learn about Cordotomy.
- Deep Brain StimulationMs. Haegelen isDistinguished. Learn about Deep Brain Stimulation.
- Advanced
- EpilepsyMs. Haegelen isAdvanced. Learn about Epilepsy.
- Movement DisordersMs. Haegelen isAdvanced. Learn about Movement Disorders.
- Parkinson's DiseaseMs. Haegelen isAdvanced. Learn about Parkinson's Disease.
- Experienced
- Cortical DysplasiaMs. Haegelen isExperienced. Learn about Cortical Dysplasia.
- EndoscopyMs. Haegelen isExperienced. Learn about Endoscopy.
- MeningoencephaloceleMs. Haegelen isExperienced. Learn about Meningoencephalocele.
- Neurotoxicity SyndromesMs. Haegelen isExperienced. Learn about Neurotoxicity Syndromes.
- SeizuresMs. Haegelen isExperienced. Learn about Seizures.